FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017673432> ?p ?o ?g. }

• W2017673432 endingPage "9" @default.
• W2017673432 startingPage "1" @default.
• W2017673432 abstract "Of 168 patients with chronic hepatitis B virus (HBV) infection-related liver disease, 20 patients who had received 100 mg of lamivudine plus 10 mg/day of adefovir dipivoxil (ADV) (ADV group) and 124 patients who had received 0.5 mg/day of entecavir or 100 mg/day of lamivudine (non-ADV group) for >1 year were enrolled. For comparative analyses, 19 well-matched pairs were obtained from the groups by propensity scores. At the time of enrollment, serum creatinine and phosphate concentrations were similar between the ADV and non-ADV groups; however, urinary phosphate () and serum bone-specific alkaline phosphatase (BAP) () concentrations were significantly higher in the ADV group than in the non-ADV group. Serum BAP was significantly higher at the time of enrollment than before ADV administration in the ADV group (), although there was no significant change in serum BAP concentration in the non-ADV group. There was a significant positive correlation between the period of ADV therapy and ΔBAP (, ). Serum BAP concentration increased before increase in serum creatinine concentration and was useful for early detection of adverse events and for developing adequate measures for continuing ADV for chronic HBV infection-related liver disease." @default.
• W2017673432 created "2016-06-24" @default.
• W2017673432 creator A5025092712 @default.
• W2017673432 creator A5033801155 @default.
• W2017673432 creator A5047402667 @default.
• W2017673432 creator A5048542767 @default.
• W2017673432 creator A5054739508 @default.
• W2017673432 creator A5055227838 @default.
• W2017673432 creator A5060154471 @default.
• W2017673432 creator A5070995972 @default.
• W2017673432 creator A5074615224 @default.
• W2017673432 date "2013-09-09" @default.
• W2017673432 modified "2023-10-16" @default.
• W2017673432 title "Elevation in Serum Concentration of Bone-Specific Alkaline Phosphatase without Elevation in Serum Creatinine Concentration Secondary to Adefovir Dipivoxil Therapy in Chronic Hepatitis B Virus Infection" @default.
• W2017673432 cites W1589406622 @default.
• W2017673432 cites W1903752002 @default.
• W2017673432 cites W1979360150 @default.
• W2017673432 cites W1986864408 @default.
• W2017673432 cites W1987753756 @default.
• W2017673432 cites W2003774451 @default.
• W2017673432 cites W2020985855 @default.
• W2017673432 cites W2027406885 @default.
• W2017673432 cites W2028516149 @default.
• W2017673432 cites W2040443681 @default.
• W2017673432 cites W2041179784 @default.
• W2017673432 cites W2044951291 @default.
• W2017673432 cites W2049234248 @default.
• W2017673432 cites W2058376942 @default.
• W2017673432 cites W2070039074 @default.
• W2017673432 cites W2071291950 @default.
• W2017673432 cites W2082928903 @default.
• W2017673432 cites W2088724567 @default.
• W2017673432 cites W2107176478 @default.
• W2017673432 cites W2121690051 @default.
• W2017673432 cites W2135386419 @default.
• W2017673432 cites W2139575022 @default.
• W2017673432 cites W2142557452 @default.
• W2017673432 cites W2152331550 @default.
• W2017673432 cites W2161280033 @default.
• W2017673432 cites W2338794667 @default.
• W2017673432 cites W3030265267 @default.
• W2017673432 cites W3149450293 @default.
• W2017673432 cites W7687383 @default.
• W2017673432 doi "https://doi.org/10.1155/2013/739247" @default.
• W2017673432 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3782837" @default.
• W2017673432 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24106611" @default.
• W2017673432 hasPublicationYear "2013" @default.
• W2017673432 type Work @default.
• W2017673432 sameAs 2017673432 @default.
• W2017673432 citedByCount "1" @default.
• W2017673432 countsByYear W20176734322014 @default.
• W2017673432 crossrefType "journal-article" @default.
• W2017673432 hasAuthorship W2017673432A5025092712 @default.
• W2017673432 hasAuthorship W2017673432A5033801155 @default.
• W2017673432 hasAuthorship W2017673432A5047402667 @default.
• W2017673432 hasAuthorship W2017673432A5048542767 @default.
• W2017673432 hasAuthorship W2017673432A5054739508 @default.
• W2017673432 hasAuthorship W2017673432A5055227838 @default.
• W2017673432 hasAuthorship W2017673432A5060154471 @default.
• W2017673432 hasAuthorship W2017673432A5070995972 @default.
• W2017673432 hasAuthorship W2017673432A5074615224 @default.
• W2017673432 hasBestOaLocation W20176734321 @default.
• W2017673432 hasConcept C126322002 @default.
• W2017673432 hasConcept C134018914 @default.
• W2017673432 hasConcept C160160445 @default.
• W2017673432 hasConcept C181199279 @default.
• W2017673432 hasConcept C203014093 @default.
• W2017673432 hasConcept C2522874641 @default.
• W2017673432 hasConcept C2776175608 @default.
• W2017673432 hasConcept C2777382497 @default.
• W2017673432 hasConcept C2777785397 @default.
• W2017673432 hasConcept C2777869810 @default.
• W2017673432 hasConcept C2778573388 @default.
• W2017673432 hasConcept C2779517838 @default.
• W2017673432 hasConcept C2780306776 @default.
• W2017673432 hasConcept C2780593183 @default.
• W2017673432 hasConcept C3020491458 @default.
• W2017673432 hasConcept C55493867 @default.
• W2017673432 hasConcept C71924100 @default.
• W2017673432 hasConcept C86803240 @default.
• W2017673432 hasConcept C90924648 @default.
• W2017673432 hasConceptScore W2017673432C126322002 @default.
• W2017673432 hasConceptScore W2017673432C134018914 @default.
• W2017673432 hasConceptScore W2017673432C160160445 @default.
• W2017673432 hasConceptScore W2017673432C181199279 @default.
• W2017673432 hasConceptScore W2017673432C203014093 @default.
• W2017673432 hasConceptScore W2017673432C2522874641 @default.
• W2017673432 hasConceptScore W2017673432C2776175608 @default.
• W2017673432 hasConceptScore W2017673432C2777382497 @default.
• W2017673432 hasConceptScore W2017673432C2777785397 @default.
• W2017673432 hasConceptScore W2017673432C2777869810 @default.
• W2017673432 hasConceptScore W2017673432C2778573388 @default.
• W2017673432 hasConceptScore W2017673432C2779517838 @default.
• W2017673432 hasConceptScore W2017673432C2780306776 @default.
• W2017673432 hasConceptScore W2017673432C2780593183 @default.
• W2017673432 hasConceptScore W2017673432C3020491458 @default.
• W2017673432 hasConceptScore W2017673432C55493867 @default.
• W2017673432 hasConceptScore W2017673432C71924100 @default.

• next